Randomized comparison between intracoronary β-radiation brachytherapy and implantation of paclitaxel-eluting stents for the treatment of diffuse in-stent restenosis

Radiotherapy and Oncology

Volumn 82, Issue 1, 2007, Pages 18-23

  Schukro, Christoph ^a   Syeda, Bonni ^a   Kirisits, Christian ^b   Schmid, Rainer ^b   Pichler, Philipp ^a   Pokrajac, Boris ^b   Lang, Irene ^a   Pötter, Richard ^b   Glogar, Dietmar ^a  

^a Department of Internal Medicine II ^*  (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Drug eluting stent; In stent restenosis; Intracoronary brachytherapy

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PACLITAXEL; RADIOISOTOPE; STRONTIUM 90; YTTRIUM 90;

ADULT; ANGIOGRAPHY; ARTICLE; BETA RADIATION; BRACHYTHERAPY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA BASE; DEATH; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; IMPLANTATION; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RESTENOSIS; REVASCULARIZATION; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BETA RAYS; BRACHYTHERAPY; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DRUG ADMINISTRATION ROUTES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; STENTS; TREATMENT OUTCOME;

EID: 33846315450     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2006.08.016     Document Type: Article

References (37)

1. Waksman R., White L.R., Chan R.C., et al. Intracoronary gamma radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis (WRIST). Circulation 101 (2000) 2165-2171
2. Leon M.B., Teirstein P.S., Moses J.W., et al. Localized intracoronary gamma radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med 344 (2001) 250-256
3. Popma J.J., Suntharalingam M., Lansky A.J., et al. Randomized trial of 90Sr/90Y beta-radiation versus placebo control for treatment of in-stent restenosis. Circulation 106 (2002) 1090-1096
4. Waksman R., Raizner A.E., Yeung A.C., Lansky A.J., and Vandertie L. Use of localised intracoronary beta radiation in treatment of in-stent restenosis: the INHIBIT randomised controlled trial. Lancet 359 (2002) 551-557
5. Suntharalingam M., Laskey W.K., Tantibhedhyangkul W., et al. Vascular brachytherapy using a beta emitter source in diabetic patients with in-stent restenosis: angiographic and clinical outcomes. Int J Radiat Oncol Biol Phys 57 (2003) 536-542
6. Waksman R., Cheneau E., Ajani A.E., et al. Washington radiation for in-stent restenosis trial for long lesions studies. Intracoronary radiation therapy improves the clinical and angiographic outcomes of diffuse in-stent restenotic lesions: results of the Washington radiation for in-stent restenosis trial for long lesions (Long WRIST) studies. Circulation 107 (2003) 1744-1749
7. Schukro C., Syeda B., Schmid R., et al. Intracoronary brachytherapy with beta-radiation for the treatment of long diffuse in-stent restenosis. Coron Artery Dis 15 (2004) 285-289
8. Morice M.C., Serruys P.W., Sousa J.E., et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
9. Moses J.W., Leon M.B., Popma J.J., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
10. Colombo A., Drzewiecki J., Banning A., et al. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 108 (2003) 788-794
11. Stone G.W., Ellis S.G., Cox D.A., et al. TAXUS-IV Investigators. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation 109 (2004) 1942-1947
12. Sousa J.E., Costa M.A., Abizaid A., et al. Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 107 (2003) 24-27
13. Degertekin M., Regar E., Tanabe K., et al. Sirolimus-eluting stent for treatment of complex in-stent restenosis: the first clinical experience. J Am Coll Cardiol 41 (2003) 184-189
14. Mehran R., Dangas G., Abizaid A.S., et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 100 (1999) 1872-1878
15. Syeda B., Siostrzonek P., Schmid R., et al. Geographical miss during intracoronary irradiation: impact on restenosis and determination of required safety margin length. J Am Coll Cardiol 40 (2002) 1225-1231
16. Schmid R., Kirisits C., Syeda B., et al. Quality assurance in intracoronary brachytherapy. Recommendations for determining the planning target length to avoid geographic miss. Radiother Oncol 71 (2004) 311-318
17. Potter R., Van Limbergen E., Dries W., et al. Recommendations of the EndoVAscular GEC ESTRO Working Group (EVA GEC ESTRO): Prescribing, recording, and reporting in endovascular brachytherapy. Quality assurance, equipment, personal and education. Radiother Oncol 59 (2001) 339-360
18. Kirisits C., Georg D., Wexberg P., Pokrajac B., Glogar D., and Potter R. Determination and application of the reference isodose length (RIL) for commercial endovascular brachytherapy devices. Radiother Oncol 64 (2002) 309-315
19. Waksman R., Ajani A.E., White R.L., et al. Prolonged antiplatelet therapy to prevent late thrombosis after intracoronary gamma-radiation in patients with in-stent restenosis: Washington radiation for in-stent restenosis trial plus 6 months of clopidogrel (WRIST PLUS). Circulation 103 (2001) 2332-2335
20. Zimarino M., Renda G., and De Caterina R. Optimal duration of antiplatelet therapy in recipients of coronary drug-eluting stents. Drugs 65 (2005) 725-732
21. Sabate M., Costa M.A., Kozuma K., et al. Geographic miss: a cause of treatment failure in radio-oncology applied to intracoronary radiation therapy. Circulation 101 (2000) 2467-2471
22. Kimura T., Abe K., Shizuta S., et al. Long-term clinical and angiographic follow-up after coronary stent placement in native coronary arteries. Circulation 105 (2002) 2986-2991
23. Tanabe K., Serruys P.W., Grube E., et al. TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation. Circulation 107 (2003) 559-564
24. Costa M., Sabate M., Van der Giessen W., et al. Late coronary occlusion after intracoronary brachytherapy. Circulation 100 (1999) 789-792
25. Waksman R., Bhargava B., Mintz G., et al. Late total occlusion after intracoronary brachytherapy for patients with in-stent restenosis. J Am Coll Cardiol 36 (2000) 65-68
26. Ajani A.E., Waksman R., Sharma A.K., et al. Three-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis: original WRIST. Washington radiation for in-stent restenosis trial. Cardiovasc Radiat Med 2 (2001) 200-204
27. Grise M.A., Massullo V., Jani S., et al. Five-year clinical follow-up after intracoronary radiation: results of a randomized clinical trial. Circulation 105 (2002) 2737-2740
28. Feres F., Munoz J.S., Abizaid A., et al. Comparison between sirolimus-eluting stents and intracoronary catheter-based Beta radiation for the treatment of in-stent restenosis. Am J Cardiol 96 (2005) 1656-1662
29. Schiele T.M., Konig A., Rieber J., et al. Sirolimus-eluting stent implantation and beta-irradiation for the treatment of in-stent restenotic lesions: comparison of underlying mechanisms of acute gain and late loss as assessed by volumetric intravascular ultrasound. Am Heart J 150 (2005) 351-357
30. Holmes D. Nine-month results from the multi-center prospective, randomized comparison of the CYPHER™ Stent versus radiation from within a vessel (brachytherapy) in patients with in-stent restenosis. TCT 2005 (abstract).
31. Chu W.W., Torguson R., Pichard A.D., et al. Drug-eluting stents versus repeat vascular brachytherapy for patients with recurrent in-stent restenosis after failed intracoronary radiation. J Invasive Cardiol 17 (2005) 659-662
32. Serruys P.W., Wijns W., Sianos G., et al. Direct stenting versus direct stenting followed by centered beta-radiation with intravascular ultrasound-guided dosimetry and long-term anti-platelet treatment: results of a randomized trial. Beta radiation investigation with direct stenting and Galileo in Europe (BRIDGE). J Am Coll Cardiol 44 (2004) 528-537
33. Sabate M., Pimentel G., Prieto C., et al. Intracoronary brachytherapy after stenting de novo lesions in diabetic patients. J Am Coll Cardiol 44 (2004) 520-527
34. Syeda B., Schukro C., Kirisits C., et al. Randomized blinded clinical trial of intracoronary brachytherapy with (90)Sr/Y beta-radiation for the prevention of restenosis after stent implantation in native coronary arteries in diabetic patients. Radiother Oncol 78 (2006) 60-66
35. Morice MC. Eight-month outcome of the REALITY study. A prospective randomized multi-center head-to-head comparison of the sirolimus-eluting stent and the paclitaxel-eluting stent. ACC 2005 (abstract).
36. Scheinert D., Strnad V., Muller R., et al. High-dose intravascular beta-radiation after de novo stent implantation induces coronary artery spasm. Circulation 105 (2002) 1420-1423
37. Kastrati A., Mehilli J., von Beckerath N., et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA 293 (2005) 165-171